Yoon Choo Email

VP, Investments and Deputy General Counsel . Royalty Pharma

Current Roles

Employees:
74
Revenue:
$2.3B
About
Royalty Pharma is the industry leader in acquiring revenue-producing intellectual property -- principally royalty interests in marketed and late stage biopharmaceutical products with approximately $5 billion in assets. Royalty Pharma currently owns a diversified portfolio of royalty interests in several high-quality blockbuster biopharmaceutical products, including Abbott's Humira(R), J&J/Centocor's Remicade(R), Pfizer's Lyrica(R), Amgen's Neupogen(R) and Neulasta(R), Genentech's Rituxan(R), Gilead's Emtriva(R), Truvada(R) and Atripla(R), and Celgene's Thalomid(R).
Royalty Pharma Address
110 E 59th Street
New York, NY
United States
Royalty Pharma Email

Past Companies

Royalty PharmaVP, Investments and Deputy General Counsel
Cleary Gottlieb Steen & Hamilton LLPAttorney At Law
GoogleSecondee - M&A Legal

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.